Universidad Francisco de Vitoria-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2024

  1. Decreased oxytocin plasma levels and oxytocin receptor expression associated with aggressive behavior in aggressive-impulsive disorders

    Journal of Psychiatric Research, Vol. 170, pp. 200-206

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

2022

  1. Dysfunction of Inflammatory Pathways and Their Relationship With Psychological Factors in Adult Female Patients With Eating Disorders

    Frontiers in Pharmacology, Vol. 13

  2. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages

    Frontiers in Molecular Biosciences, Vol. 9

2021

  1. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis

    Brain Pathology, Vol. 31, Núm. 6

  4. Inflammatory dysregulation in women with an eating disorder: Relationships with altered emotional reactivity

    International Journal of Eating Disorders, Vol. 54, Núm. 10, pp. 1843-1854

2020

  1. Multivalent cationic dendrofullerenes for gene transfer: synthesis and DNA complexation

    Journal of Materials Chemistry B, Vol. 8, Núm. 20, pp. 4505-4515

  2. Targeting tlr4 with aptoll improves heart function in response to coronary ischemia reperfusion in pigs undergoing acute myocardial infarction

    Biomolecules, Vol. 10, Núm. 8, pp. 1-13

2018

  1. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

    Biochemical Pharmacology, Vol. 157, pp. 67-84

2015

  1. Endocannabinoids and Neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others

    Handbook of Experimental Pharmacology (Springer New York LLC), pp. 233-259

2014

  1. Protein kinase D activity controls endothelial nitric oxide synthesis

    Journal of Cell Science, Vol. 127, Núm. 15, pp. 3360-3372